These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17031382)

  • 1. Species and response dependent differences in the effects of MAPK inhibitors on P2X(7) receptor function.
    Michel AD; Thompson KM; Simon J; Boyfield I; Fonfria E; Humphrey PP
    Br J Pharmacol; 2006 Dec; 149(7):948-57. PubMed ID: 17031382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells.
    Donnelly-Roberts DL; Namovic MT; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1053-61. PubMed ID: 14634045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.
    Michel AD; Xing M; Humphrey PP
    Br J Pharmacol; 2001 Apr; 132(7):1501-8. PubMed ID: 11264244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.
    Stokes L; Jiang LH; Alcaraz L; Bent J; Bowers K; Fagura M; Furber M; Mortimore M; Lawson M; Theaker J; Laurent C; Braddock M; Surprenant A
    Br J Pharmacol; 2006 Dec; 149(7):880-7. PubMed ID: 17031385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.
    Michel AD; Fonfria E
    Br J Pharmacol; 2007 Oct; 152(4):523-37. PubMed ID: 17700717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of P2X7 purinoceptor-stimulated TGF-beta 1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line, RBA-2.
    Wang CM; Chang YY; Sun SH
    Cell Signal; 2003 Dec; 15(12):1129-37. PubMed ID: 14575868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent species differences in the kinetic properties of P2X(7) receptors.
    Hibell AD; Kidd EJ; Chessell IP; Humphrey PP; Michel AD
    Br J Pharmacol; 2000 May; 130(1):167-73. PubMed ID: 10781013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells.
    Milius D; Gröger-Arndt H; Stanchev D; Lange-Dohna C; Rossner S; Sperlagh B; Wirkner K; Illes P
    Toxicology; 2007 Aug; 238(1):60-9. PubMed ID: 17618031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cells.
    Chung HS; Park KS; Cha SK; Kong ID; Lee JW
    Br J Pharmacol; 2000 Aug; 130(8):1843-52. PubMed ID: 10952673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X7 receptors stimulate AKT phosphorylation in astrocytes.
    Jacques-Silva MC; Rodnight R; Lenz G; Liao Z; Kong Q; Tran M; Kang Y; Gonzalez FA; Weisman GA; Neary JT
    Br J Pharmacol; 2004 Apr; 141(7):1106-17. PubMed ID: 15023862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho.
    Pfeiffer ZA; Aga M; Prabhu U; Watters JJ; Hall DJ; Bertics PJ
    J Leukoc Biol; 2004 Jun; 75(6):1173-82. PubMed ID: 15075366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of P2X7 receptors in rat peritoneal cells.
    Chen YW; Donnelly-Roberts DL; Namovic MT; Gintant GA; Cox BF; Jarvis MF; Harris RR
    Inflamm Res; 2005 Mar; 54(3):119-26. PubMed ID: 15883745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice.
    Fu W; McCormick T; Qi X; Luo L; Zhou L; Li X; Wang BC; Gibbons HE; Abdul-Karim FW; Gorodeski GI
    BMC Cancer; 2009 Apr; 9():114. PubMed ID: 19379509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative and positive allosteric modulators of the P2X(7) receptor.
    Michel AD; Chambers LJ; Walter DS
    Br J Pharmacol; 2008 Feb; 153(4):737-50. PubMed ID: 18071294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors.
    Michel AD; Xing M; Thompson KM; Jones CA; Humphrey PP
    Eur J Pharmacol; 2006 Mar; 534(1-3):19-29. PubMed ID: 16487507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases.
    Barbieri R; Alloisio S; Ferroni S; Nobile M
    Neurochem Int; 2008 Dec; 53(6-8):255-62. PubMed ID: 18804898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore.
    Schilling WP; Wasylyna T; Dubyak GR; Humphreys BD; Sinkins WG
    Am J Physiol; 1999 Oct; 277(4):C766-76. PubMed ID: 10516107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation.
    da Cruz CM; Ventura AL; Schachter J; Costa-Junior HM; da Silva Souza HA; Gomes FR; Coutinho-Silva R; Ojcius DM; Persechini PM
    Br J Pharmacol; 2006 Feb; 147(3):324-34. PubMed ID: 16341234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of P2X7 receptors elevates Ca2+ and kills retinal ganglion cells.
    Zhang X; Zhang M; Laties AM; Mitchell CH
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2183-91. PubMed ID: 15914640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP, a partial agonist for the P2Z receptor of human lymphocytes.
    Gargett CE; Cornish JE; Wiley JS
    Br J Pharmacol; 1997 Nov; 122(5):911-7. PubMed ID: 9384508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.